ETON
ETON
US29772L1089
Eton Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 79.950.000 39.011.000
104.9%
Cost of Revenue 37.210.000 15.600.000
138.5%
Gross Profit 42.740.000 23.411.000
82.6%
43.584.000 26.008.000
67.6%
Operating Income -844.000 -2.597.000
67.5%
Pretax Income -4.558.000 -3.808.000
19.7%
Net Income Common Stockholders -4.601.000 -3.823.000
20.4%
-- --
--
-- --
--
ende